Po‐Min Chen

2.5k total citations
87 papers, 1.9k citations indexed

About

Po‐Min Chen is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Po‐Min Chen has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Hematology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Po‐Min Chen's work include Lymphoma Diagnosis and Treatment (16 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (11 papers). Po‐Min Chen is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (11 papers). Po‐Min Chen collaborates with scholars based in Taiwan, United States and United Kingdom. Po‐Min Chen's co-authors include Wei-Shu Wang, Tzeon-Jye Chiou, Liu H, Chueh‐Chuan Yen, Muh‐Hwa Yang, Liang-Tsai Hsiao, Huann-Sheng Wang, Cheng‐Hwai Tzeng, Frank S. Fan and Shyue‐Yih Chang and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Po‐Min Chen

86 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Min Chen Taiwan 23 705 500 283 275 252 87 1.9k
Yubin Kang United States 24 614 0.9× 748 1.5× 133 0.5× 457 1.7× 145 0.6× 97 1.9k
Jonathan Fawcett Australia 25 527 0.7× 682 1.4× 572 2.0× 126 0.5× 446 1.8× 78 2.4k
Jan Eucker Germany 29 760 1.1× 1.0k 2.1× 110 0.4× 628 2.3× 401 1.6× 85 2.5k
Yoshito Takeda Japan 22 581 0.8× 614 1.2× 112 0.4× 203 0.7× 201 0.8× 113 2.0k
E. Thiel Germany 28 646 0.9× 698 1.4× 172 0.6× 625 2.3× 256 1.0× 121 2.5k
Grazia Malaponte Italy 25 433 0.6× 637 1.3× 221 0.8× 102 0.4× 185 0.7× 53 1.8k
Stefanie Hammer Germany 23 545 0.8× 835 1.7× 216 0.8× 132 0.5× 407 1.6× 63 2.1k
Arnaldo Arbini United States 25 433 0.6× 905 1.8× 126 0.4× 408 1.5× 106 0.4× 55 1.9k
J.H. Goldie Canada 20 480 0.7× 384 0.8× 307 1.1× 133 0.5× 148 0.6× 53 1.4k

Countries citing papers authored by Po‐Min Chen

Since Specialization
Citations

This map shows the geographic impact of Po‐Min Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Min Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Min Chen more than expected).

Fields of papers citing papers by Po‐Min Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Min Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Min Chen. The network helps show where Po‐Min Chen may publish in the future.

Co-authorship network of co-authors of Po‐Min Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Min Chen. A scholar is included among the top collaborators of Po‐Min Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Min Chen. Po‐Min Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Huai‐Che, Li-Yu Fay, Chiu-Mei Yeh, et al.. (2019). Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma. Journal of Cancer. 10(17). 3958–3966. 8 indexed citations
2.
Hsiao, Liang-Tsai, Hao‐Yuan Wang, Tzeon-Jye Chiou, et al.. (2016). Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients. Medicine. 95(11). e3064–e3064. 9 indexed citations
3.
Chien, Sheng‐Hsuan, Jyh-Pyng Gau, Chia‐Jen Liu, et al.. (2016). Prognostic Factors on the Graft‐versus‐Host Disease‐Free and Relapse‐Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation. Stem Cells International. 2016(1). 5143071–5143071. 14 indexed citations
4.
Wang, Hao‐Yuan, Tzeon-Jye Chiou, Jyh-Pyng Gau, et al.. (2014). A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin. Medicine. 93(27). e243–e243. 11 indexed citations
5.
Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Jyh-Pyng Gau, et al.. (2014). Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B. Leukemia & lymphoma. 56(8). 2357–2364. 12 indexed citations
6.
Liu, Chun‐Yu, Hsueh‐Ju Lu, Man‐Hsin Hung, et al.. (2013). Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era. Annals of Hematology. 92(11). 1513–1520. 15 indexed citations
7.
Liu, Chun‐Yu, Muh‐Hwa Yang, Hui-Chi Hsu, et al.. (2012). A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thrombosis and Haemostasis. 108(8). 225–235. 90 indexed citations
8.
Liu, Chun‐Yu, Ying-Chung Hong, Yuan-Bin Yu, et al.. (2010). Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience. Leukemia & lymphoma. 51(12). 2208–2214. 13 indexed citations
9.
Hong, Ying-Chung, Liang-Tsai Hsiao, Yuan-Bin Yu, et al.. (2010). Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia. European Journal Of Haematology. 86(3). 237–245. 3 indexed citations
10.
Yang, Muh‐Hwa, Chi-Hung Huang, Shyue‐Yih Chang, et al.. (2009). Interaction between HSP60 and β-catenin promotes metastasis. Carcinogenesis. 30(6). 1049–1057. 97 indexed citations
11.
Huang, Chi-Hung, Po‐Min Chen, Tzeon-Jye Chiou, et al.. (2009). Purified Recombinant TAT-Homeobox B4 Expands CD34 + Umbilical Cord Blood and Peripheral Blood Progenitor Cells Ex Vivo. Tissue Engineering Part C Methods. 16(3). 487–496. 11 indexed citations
12.
Chen, Ming‐Huang, Tzeon-Jye Chiou, Peng-Chan Lin, et al.. (2007). Comparison of Myeloablative and Nonmyeloablative Hematopoietic Stem Cell Transplantation for Treatment of Chronic Myeloid Leukemia. International Journal of Hematology. 86(3). 275–281. 7 indexed citations
13.
Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Liu H, et al.. (2006). Extended Lamivudine Therapy against Hepatitis B Virus Infection in Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 12(1). 84–94. 35 indexed citations
14.
Lin, Peng-Chan, Ming-Yang Lee, Wei-Shu Wang, et al.. (2006). N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Supportive Care in Cancer. 14(5). 484–487. 89 indexed citations
15.
Lin, Peng-Chan, Wei-Shu Wang, Muh‐Hwa Yang, et al.. (2006). Sequential Therapy with Capecitabine Followed by Vinorelbine/Cisplatin in Patients with Anthracycline/Taxane-refractory Metastatic Breast Cancer. Journal of the Chinese Medical Association. 69(7). 304–309. 3 indexed citations
16.
Lin, Peng-Chan, et al.. (2005). Fatal Fulminant Hepatitis B after Withdrawal of Prophylactic Lamivudine in Hematopoietic Stem Cell Transplantation Patients. International Journal of Hematology. 81(4). 349–351. 21 indexed citations
17.
H, Liu, Wei-Shone Chen, Chueh‐Chuan Yen, et al.. (2004). An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells. Biochemical and Biophysical Research Communications. 318(3). 764–772.
18.
Bai, Li‐Yuan, Muh‐Hwa Yang, Tzeon‐Jye Chiou, et al.. (2003). Non‐Hodgkin lymphoma in elderly patients. Cancer. 98(6). 1188–1195. 5 indexed citations
19.
Wang, Wei-Shu, et al.. (2003). All-trans retinoid acid increases Notch1 transcript expression in acute promyelocytic leukemia. Advances in Therapy. 20(6). 337–343. 6 indexed citations
20.
Chiou, Tzeon-Jye, Shiao-Lin Tung, Wei-Shu Wang, et al.. (2002). Pulmonary Function Changes in Long-Term Survivors of Chronic Myelogenous Leukemia After Allogeneic Bone Marrow Transplantation: A Taiwan Experience. Cancer Investigation. 20(7-8). 880–888. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yubin Kang Breakdown of academic impact, for papers by Jonathan Fawcett Breakdown of academic impact, for papers by Jan Eucker Breakdown of academic impact, for papers by Yoshito Takeda Breakdown of academic impact, for papers by E. Thiel Breakdown of academic impact, for papers by Grazia Malaponte Breakdown of academic impact, for papers by Stefanie Hammer Breakdown of academic impact, for papers by Arnaldo Arbini Breakdown of academic impact, for papers by J.H. Goldie
Rankless by CCL
2026